Long-term toxicity after therapy for testicular cancer with special focus on sexual disorders

被引：0
|
作者：
Oldenburg, J. [1 ,2 ]
Fossa, S. D. [1 ,3 ]
机构：
[1] Norwegian Radium Hosp, Dept Clin Canc Res, N-0310 Oslo, Norway
[2] Buskerud Univ Coll, Inst Hlth, Drammen, Norway
[3] Univ Oslo, Fac Med, Oslo, Norway
来源：
UROLOGE | 2009年 / 48卷 / 04期
关键词：
Testicular cancer; Long-term complications; Chemotherapy; Radiotherapy; Fertility; GERM-CELL MALIGNANCIES; QUALITY-OF-LIFE; SURVIVORS; RISK; EXPERIENCE;
D O I：
10.1007/s00120-009-1945-0
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Due to cisplatin-based chemotherapy, the survival rate of testicular cancer patients approaches 90%. Chemo- or radiotherapy may cause long-term complications, e.g. cardiovascular disease, secondary cancers and reduced fertility. Sperm cryopreservation is recommended depending on the extent of therapy and should be performed before orchiectomy. Furthermore, patients should be informed about long-term complications and their possible reduction by optimizing the risk factor profile.
引用
收藏
页码：372 / 376
页数：5
相关论文
共 50 条
  • [31] Short- and long-term morbidity after treatment for testicular cancer
    Fossa, Sophie D.
    Oldenburg, Jan
    Dahl, Alv A.
    BJU INTERNATIONAL, 2009, 104 (9B) : 1418 - 1422
  • [32] LONG-TERM RECOVERY OF SPERMATOGENESIS AFTER RADIOTHERAPY IN PATIENTS WITH TESTICULAR CANCER
    HANSEN, PV
    TRYKKER, H
    SVENNEKJAER, IL
    HVOLBY, J
    RADIOTHERAPY AND ONCOLOGY, 1990, 18 (02) : 117 - 125
  • [33] Second cancers among 40576 testicular cancer patients:: Focus on long-term survivors
    Travis, LB
    Fosså, SD
    Schonfeld, SJ
    McMaster, ML
    Lynch, CF
    Storm, H
    Hall, P
    Holowaty, E
    Andersen, A
    Pukkala, E
    Andersson, M
    Kaijser, M
    Gospodarowicz, M
    Joensuu, T
    Cohen, RJ
    Boice, JD
    Dores, GM
    Gilbert, ES
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (18): : 1354 - 1365
  • [34] WHAT ARE THE MAIN VARIABLES ASSOCIATED WITH SEXUAL PROBLEMS IN LONG-TERM TESTICULAR CANCER SURVIVORS?
    Dahl, A. A.
    Bremnes, R.
    Dahl, O.
    Klepp, O.
    Wist, E.
    Fossa, S. D.
    ANNALS OF ONCOLOGY, 2008, 19 : 188 - 188
  • [35] Risk of cancer after long-term therapy of autoimmune disorders with glucocorticoids or DMARDs—a controversial issue
    Jakob D. Rudzki
    memo - Magazine of European Medical Oncology, 2019, 12 : 225 - 229
  • [36] Long-term survivors of testicular cancer - In reply
    Huddart, RA
    Norman, A
    JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (20) : 3888 - 3889
  • [37] Long-term Morbidity of Testicular Cancer Treatment
    Fung, Chunkit
    Fossa, Sophie D.
    Williams, Annalynn
    Travis, Lois B.
    UROLOGIC CLINICS OF NORTH AMERICA, 2015, 42 (03) : 393 - +
  • [38] Long-term complications of testicular cancer treatment
    Witjes, J. A.
    Van Der Schans, S.
    Spermon, R.
    Kiemeney, L. A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 157 - 157
  • [39] Evaluation of long-term toxicity in patients after cisplatin-based chemotherapy for non-seminomatous testicular cancer
    Strumberg, D
    Brügge, S
    Korn, MW
    Koeppen, S
    Ranft, J
    Scheibert, G
    Reiners, C
    Möckel, C
    Seeber, S
    Scheulen, ME
    ANNALS OF ONCOLOGY, 2002, 13 (02) : 229 - 236
  • [40] LONG-TERM MORBIDITY AFTER INFRADIAPHRAGMATIC RADIOTHERAPY IN YOUNG MEN WITH TESTICULAR CANCER
    FOSSA, SD
    AASS, N
    KAALHUS, O
    CANCER, 1989, 64 (02) : 404 - 408
12345